Pola Pharma Inc.
Records under this name other than the patents Pola Pharma Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 22 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,962,669 | Antimycotic Pharmaceutical Composition Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 9,068,958 | Use of Surface Free Energy for Differential Evaluation of Crystal, Crystal Evaluated on Basis of Surface Free Energy as Index, and Pharmaceutical Composition Prepared by Containing the Crystal Formerly held In force · High confidence | In force | High confidence | |
| US 11,400,076 | Cancer Stem Cell Inhibitor Formerly held Lapsed on the fee record Ended Aug 2, 2026 · Medium confidence | Lapsed on the fee record | Ended Aug 2, 2026 | Medium confidence |
| US 11,135,297 | External-use composition producing foamed state upon use Lapsed on the fee record Ended Oct 5, 2025 · From the USPTO record | Lapsed on the fee record | Ended Oct 5, 2025 | From the USPTO record |
| US 8,541,459 | Pharmaceutical composition Lapsed on the fee record Ended Sep 24, 2025 · From the USPTO record | Lapsed on the fee record | Ended Sep 24, 2025 | From the USPTO record |
| US 8,450,356 | Pharmaceutical composition Lapsed on the fee record Ended May 28, 2025 · From the USPTO record | Lapsed on the fee record | Ended May 28, 2025 | From the USPTO record |
| US 8,420,687 | Pharmaceutical composition Lapsed on the fee record Ended Apr 16, 2025 · From the USPTO record | Lapsed on the fee record | Ended Apr 16, 2025 | From the USPTO record |
| US 9,562,912 | Method of identifying abnormal cells by expression levels of ETFB Lapsed on the fee record Ended Feb 7, 2025 · From the USPTO record | Lapsed on the fee record | Ended Feb 7, 2025 | From the USPTO record |
| US 9,491,933 | Infected nail of animal infected with fungus Lapsed on the fee record Ended Nov 15, 2024 · From the USPTO record | Lapsed on the fee record | Ended Nov 15, 2024 | From the USPTO record |
| US 8,258,165 | Pharmaceutical composition Lapsed on the fee record Ended Sep 4, 2024 · From the USPTO record | Lapsed on the fee record | Ended Sep 4, 2024 | From the USPTO record |